These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31840266)

  • 1. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism.
    Kietsiriroje N; Wonghirundecha R; Suntornlohanakul O; Murray RD
    Clin Endocrinol (Oxf); 2020 Mar; 92(3):196-205. PubMed ID: 31840266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
    Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
    PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
    Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison between screening for primary aldosteronism with and without drug adjustment.
    Hua Y; He Q
    Blood Press; 2024 May; 33(1):2350981. PubMed ID: 38824645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
    Seiler L; Rump LC; Schulte-Mönting J; Slawik M; Borm K; Pavenstädt H; Beuschlein F; Reincke M
    Eur J Endocrinol; 2004 Mar; 150(3):329-37. PubMed ID: 15012618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline Plasma Aldosterone Level and Renin Activity Allowing Omission of Confirmatory Testing in Primary Aldosteronism.
    Kawashima J; Araki E; Naruse M; Kurihara I; Takahashi K; Tamura K; Kobayashi H; Okamura S; Miyauchi S; Yamamoto K; Izawa S; Suzuki T; Tanabe A
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32157288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
    Wu VC; Kuo CC; Chang HW; Tsai CT; Lin CY; Lin LY; Lin YH; Wang SM; Huang KH; Fang CC; Ho YL; Liu KL; Chang CC; Chueh SC; Lin SL; Yen RF; Wu KD;
    Clin Chim Acta; 2010 May; 411(9-10):657-63. PubMed ID: 20117105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism.
    Guo Z; Poglitsch M; McWhinney BC; Ungerer JPJ; Ahmed AH; Gordon RD; Wolley M; Stowasser M
    J Clin Endocrinol Metab; 2018 Nov; 103(11):3965-3973. PubMed ID: 30137438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sparing confirmatory testing in primary aldosteronism (SCIPA): a multicenter retrospective diagnostic accuracy study.
    Ong Lopez AMC; Tiu LE; Dimayuga DC; Dampil OAC; Mendoza ES; Villa ML; Macabuag-Oliva AM
    BMC Endocr Disord; 2024 Jul; 24(1):105. PubMed ID: 38978003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of primary aldosteronism diagnosis in initial evaluation without medication withdrawal or confirmatory tests.
    Ruiz-Sánchez JG; Fernández Sánchez Á; Meneses D
    Endocrine; 2024 Aug; 85(2):906-915. PubMed ID: 38568364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
    Chen WG; Zhou TT; Zhou P; Li XW; Wu Z; Zhang KY; Xing JC
    Int J Clin Exp Pathol; 2015; 8(6):6901-9. PubMed ID: 26261577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].
    Omura M; Nishikawa T
    Rinsho Byori; 2006 Nov; 54(11):1157-63. PubMed ID: 17240838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the ratio of plasma aldosterone to rennin concentration measured by an automated chemiluminescent immunoassay in screening for primary aldosteronism].
    Song Y; He W; Yang S; Cheng Q; Hu J; Zhen Q; Long J; Feng Z; Li R; Wang Z; Ren W; Zhou B; Li Q
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):6-10. PubMed ID: 26796645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Biochemical Conditions Allowing Bypass of Confirmatory Testing in The Workup of Primary Aldosteronism: A Retrospective Study in a French Hypertensive Population.
    Vivien M; Deberles E; Morello R; Haddouche A; Guenet D; Reznik Y
    Horm Metab Res; 2019 Mar; 51(3):172-177. PubMed ID: 30861563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL; Opie LH; Davidson JS
    S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening.
    Yin G; Zhang S; Yan L; Wu M; Xu M; Li F; Cheng H
    Exp Clin Endocrinol Diabetes; 2012 Jul; 120(7):388-94. PubMed ID: 22689101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.